论文部分内容阅读
目的:分析稳心颗粒联合普罗帕酮治疗房颤的临床疗效。方法:选取2012年12月-2013年12月来我院治疗的76例房颤患者作为临床研究对象,按照入院尾号的奇偶数将其分为观察组和对照组,38例对照组患者给予普罗帕酮治疗,38例观察组患者在对照组患者治疗基础上给予稳心颗粒治疗。结果:观察组患者的治疗总有效率显著高于对照组(P<0.05);两组患者的不良反应率对比无明显差异(P>0.05);观察组患者的复发率显著低于对照组(P<0.05)。结论:对房颤患者采用稳心颗粒联合普罗帕酮进行治疗,治疗效果较为显著,且不良反应较少,复发率较低,值得临床广泛推广。
OBJECTIVE: To analyze the clinical effect of Wenxin Granule combined with propafenone in the treatment of atrial fibrillation. Methods: A total of 76 patients with atrial fibrillation who were treated in our hospital from December 2012 to December 2013 were enrolled in this study. They were divided into observation group and control group according to the even and odd number of admission tail number. 38 patients in control group were given Propafenone treatment, 38 cases of observation group patients in the control group based on the treatment given Wenxin particles treatment. Results: The total effective rate in the observation group was significantly higher than that in the control group (P <0.05). There was no significant difference in the adverse reaction rate between the two groups (P> 0.05). The recurrence rate in the observation group was significantly lower than that in the control group P <0.05). Conclusion: The treatment of patients with atrial fibrillation with Wenxin granule combined with propafenone has a significant therapeutic effect, with fewer adverse reactions and a lower recurrence rate, which deserves wide application in clinic.